European Heart Journal Advance Access originally published online on March 17, 2005
European Heart Journal 2005 26(10):943-945; doi:10.1093/eurheartj/ehi235
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The European Society of Cardiology 2005. All rights reserved. For Permissions, please e-mail: journals.permissions@oupjournals.org
Heart rate: a strong predictor of mortality in subjects with coronary artery disease
Clinica Medica 4-University of Padova, via Giustiniani, 2-35128 Padova, Italy
* Corresponding author. Tel: +39 049 821 2278; fax: +39 049 875 4179. E-mail address: palatini@unipd.it
| The first 10% of the full text of this article appears below. |
This editorial refers to ‘Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease’
by A. Diaz et al., on page 967
Risk stratification is important for determining the prognosis of subjects at moderate to high cardiovascular risk and various attempts have been made to integrate several clinical variables into a user-friendly risk model. Recently, the ESC has developed a model called SCORE which incorporates age, gender, smoking, systolic blood pressure, and total cholesterol (or total cholesterol/HDL-cholesterol ratio).1 This model does not take into account several other risk factors for cardiovascular disease, which may be relevant for modulating the disease risk, on the grounds that their impact on risk estimation is still uncertain. In the SCORE project article, resting heart rate was not even included in the
CiteULike 
Connotea 
Del.icio.us What's this?
Related articles in EHJ:
- Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease
- Ariel Diaz, Martial G. Bourassa, Marie-Claude Guertin, and Jean-Claude Tardif
EHJ 2005 26: 967-974.[Abstract] [FREE Full Text]
This article has been cited by other articles:
|
|
 |
|
  P. G. Steg Heart rate management in coronary artery disease: the CLARIFY registry Eur. Heart J. Suppl., August 1, 2009; 11(suppl_D): D13 - D18. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-C. Tardif Heart rate as a treatable cardiovascular risk factor Br. Med. Bull., June 1, 2009; 90(1): 71 - 84. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Bangalore, S. Sawhney, and F. H. Messerli Relation of Beta-Blocker-Induced Heart Rate Lowering and Cardioprotection in Hypertension J. Am. Coll. Cardiol., October 28, 2008; 52(18): 1482 - 1489. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Borer Heart rate: from risk marker to risk factor Eur. Heart J. Suppl., August 1, 2008; 10(suppl_F): F2 - F6. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Kolloch, U. F. Legler, A. Champion, R. M. Cooper-DeHoff, E. Handberg, Q. Zhou, and C. J. Pepine Impact of resting heart rate on outcomes in hypertensive patients with coronary artery disease: findings from the INternational VErapamil-SR/trandolapril STudy (INVEST) Eur. Heart J., May 2, 2008; 29(10): 1327 - 1334. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Khattab, A. A. Khattab, J. Ortak, G. Richardt, and H. Bonnemeier Iyengar Yoga Increases Cardiac Parasympathetic Nervous Modulation Among Healthy Yoga Practitioners Evid. Based Complement. Altern. Med., December 1, 2007; 4(4): 511 - 517. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Swedberg Pure heart rate reduction: further perspectives in heart failure Eur. Heart J. Suppl., September 1, 2007; 9(suppl_F): F20 - F24. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O Rogowski, I Shapira, A Shirom, S Melamed, S Toker, and S Berliner Heart rate and microinflammation in men: a relevant atherothrombotic link Heart, August 1, 2007; 93(8): 940 - 944. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Michalsen and G. J. Dobos Heart rate reduction through lifestyle modification Eur. Heart J., September 1, 2005; 26(17): 1806 - 1807. [Full Text] [PDF]
|
|